These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
467 related items for PubMed ID: 21946514
1. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis. Hung WT, Chen YM, Lan JL, Chen HH, Chen YH, Chen DY, Hsieh CW, Wen MC. Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514 [Abstract] [Full Text] [Related]
2. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ. Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738 [Abstract] [Full Text] [Related]
3. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC. Arthritis Rheum; 2000 Jan 02; 43(1):76-84. PubMed ID: 10643702 [Abstract] [Full Text] [Related]
4. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Saisoong S, Eiam-Ong S, Hanvivatvong O. Clin Exp Rheumatol; 2006 Jan 02; 24(1):51-8. PubMed ID: 16539819 [Abstract] [Full Text] [Related]
5. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M. Lupus; 2011 Oct 02; 20(12):1267-74. PubMed ID: 21813587 [Abstract] [Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G. Clin Rheumatol; 2003 Oct 02; 22(4-5):271-8. PubMed ID: 14576989 [Abstract] [Full Text] [Related]
7. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Ng KP, Manson JJ, Rahman A, Isenberg DA. Arthritis Rheum; 2006 Dec 15; 55(6):900-4. PubMed ID: 17139667 [Abstract] [Full Text] [Related]
8. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Pradhan VD, Patwardhan MM, Ghosh K. Indian J Dermatol Venereol Leprol; 2010 Dec 15; 76(2):145-9. PubMed ID: 20228543 [Abstract] [Full Text] [Related]
9. Antinucleosome antibodies and systemic lupus erythematosus. Düzgün N, Sahin M, Genç Y, Tutkak H. Ann N Y Acad Sci; 2007 Aug 15; 1109():421-8. PubMed ID: 17785331 [Abstract] [Full Text] [Related]
10. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Mok CC, Ho LY, Leung HW, Wong LG. Transl Res; 2010 Dec 15; 156(6):320-5. PubMed ID: 21078493 [Abstract] [Full Text] [Related]
11. Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in human and murine systemic lupus erythematosus. Jørgensen MH, Rekvig OP, Jacobsen RS, Jacobsen S, Fenton KA. Immunol Lett; 2011 Aug 30; 138(2):179-86. PubMed ID: 21530588 [Abstract] [Full Text] [Related]
12. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement. Ezzat M, El-Gammasy T, Shaheen K, Shokr E. Lupus; 2011 Jul 30; 20(8):845-54. PubMed ID: 21576203 [Abstract] [Full Text] [Related]
13. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA. Autoimmunity; 2013 May 30; 46(3):205-14. PubMed ID: 23331132 [Abstract] [Full Text] [Related]
14. [Laboratory and morphologic parameters in patients with lupus nephritis]. Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V. Srp Arh Celok Lek; 2002 Aug 30; 130 Suppl 3():38-41. PubMed ID: 12583312 [Abstract] [Full Text] [Related]
15. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis. Alzawawy A, Zohary M, Ablordiny M, Eldalie M. Int J Rheum Dis; 2009 Dec 30; 12(4):311-8. PubMed ID: 20374368 [Abstract] [Full Text] [Related]
16. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA. Ann Rheum Dis; 2009 Feb 30; 68(2):234-7. PubMed ID: 18718989 [Abstract] [Full Text] [Related]
17. [Serological and histological study of lupus nephritis with special reference to anti-SSA antibody]. Nakashima A. Nihon Jinzo Gakkai Shi; 1989 Jul 30; 31(7):743-55. PubMed ID: 2585828 [Abstract] [Full Text] [Related]
18. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC, Zhou B, Dong Y. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001 [Abstract] [Full Text] [Related]
19. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC. Arthritis Res Ther; 2006 Apr 13; 8(6):R162. PubMed ID: 17062137 [Abstract] [Full Text] [Related]
20. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients. Gao JX, Diao HL, Liu YQ, Lv M, Dong H, Zhang XM, Wang YN. J Biol Regul Homeost Agents; 2015 Apr 13; 29(1):201-6. PubMed ID: 25864759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]